Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Cancer Prevention: Methodological Pitfalls in Observational Studies
Cancer prevention through GLP-1 receptor agonist use should be explored; however, there are several methodological challenges to overcome in understanding this link before it can inform clinical practice and policy.
Authors
- Andrew G. Renehan (ORCID: https://orcid.org/0000-0003-4309-4396)
- Matthew Harris (ORCID: https://orcid.org/0000-0002-7326-3413)
- Michelle Harvie (ORCID: https://orcid.org/0000-0001-9761-3089)
Institutions
- University of Manchester (GB)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-26
- DOI
- https://doi.org/10.3390/cancers17091451
- Citations
- 4
- Primary Topic
- Statistical Methods in Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 10.52
Funders
- Cancer Research UK
- National Institute for Health and Care Research
- Manchester Biomedical Research Centre